Pittsburgh Gut Club: Fecal Microbial Transplant for C diff and IBD 9.30.21

September 30, 2021

Target Audience

Nurse

Nurse Practitioner

Physician

Physician Assistant

Psychologist

Social Workers

Learning Objectives

Review state-of-the-art information on the pathogenesis of gastrointestinal and liver diseases.

• Review the latest procedural and diagnostic advancements for gastroenterology practice.

• Identify current treatments available for GI diseases and discuss future advancements

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.00 Attendance
Course opens: 
08/10/2021
Course expires: 
12/30/2021
Event starts: 
09/30/2021 - 6:30pm EDT
Event ends: 
09/30/2021 - 7:30pm EDT

6 p.m. Welcome, Registration, Visit Exhibitors

6:30 p.m. Lecture & Discussion

7:30 p.m. Adjourn and Visit Exhibitors

8 p.m. Sponsorship Website Closes

Jessica R. Allegretti, MD, MPH Assistant Professor of Medicine Harvard University Director of Clinical Research Director, Fecal Microbiota Transplant Program Associate Director, Crohn's and Colitis Center Division of Gastroenterology, Hepatology and Endoscopy Brigham and Women's Hospital

The following relevant financial relationships were disclosed:

Jessica Allegretti receives Grants/Research support from Merck and is a consultant for Merck, Pfizer, Janssen, Artugen, Servatus, Finch Therapeutics, Iterative Scopes, BMS, Baccain, Pandion, and Morphic.

Robert E Schoen, MD MPH receives Grants/Research support from Medtronic, Freenome

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose. 

Accreditation and credit designation 

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician (CME) 

The University of Pittsburgh School designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Other Healthcare Professionals 

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity. 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.00 Attendance

Bristol Myer Squibb,

Exact Sciences,

Ferring Pharmaceuticals,

Gilead Science, Inc., 

Ipsen Biopharmaceuticals, Inc.

Janssen Biotech

Takeda

Olympus America Inc.

 

Please login or register to take this course.